RASL

What RASL does

RASL is a privately held drug testing laboratory headquartered in Melbourne, Australia, founded in 1988. The company provides laboratory testing services across three distinct sample categories — equine, canine, and human — operating as a specialized analytical services provider rather than a technology platform. With an employee count in the 11-50 range, RASL is a small, established niche laboratory positioned at the intersection of veterinary (racing industry and working dogs), and human clinical or workplace drug testing markets.

The firm's operating model is built on conventional analytical laboratory infrastructure — sample receipt, preparation, and chemical analysis — rather than disclosed proprietary technology platforms or software products. The multi-species service offering implies shared laboratory overhead across three different customer verticals, with each vertical likely subject to its own regulatory and accreditation regime (e.g., racing integrity bodies for equine, veterinary standards for canine, and clinical/forensic standards for human). No products, pricing tiers, named customers, partnerships, or technology stack details are documented in the available input.

Revenue mechanics are not disclosed. As a private, unfunded (no funding rounds documented) services business operating from a single Melbourne site, RASL appears to monetize via per-sample testing fees billed to racing authorities, veterinary clinics, employers, or clinical referrers. No go-to-motion, marketing channels, distribution approach, or pricing model details are available. The input data is materially incomplete — the firm's own website returned only a loading/verification page — limiting further granularity on business model, customer mix, or competitive positioning.

Name

RASL

Website

https://rasl.com.au

Company type

Private

Founded year

1988

Headcount range

11–50 employees

Short description

RASL is an Australian drug testing laboratory in Melbourne, founded in 1988, providing analytical lab testing services for equine, canine, and human samples across veterinary, racing, and clinical customer segments.

Ownership category

akta.pro rank

Product category

Drug Testing Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Drug testing laboratory
• Equine drug testing
• Human drug screening
• Canine drug testing
• Analytical laboratory services

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Core offering

RASL is a drug testing laboratory that provides analytical laboratory testing services for equine, canine, and human samples. The company operates as a private for-profit laboratory founded in 1988, headquartered in Melbourne, Australia, with a workforce of 11-50 employees.

Differentiator

Problem solved

Functional benefit

Products and services

• Equine Drug Testing Analytical laboratory drug testing services performed on equine samples, typically for racing authorities, trainers, owners, and veterinary clinics.
• Canine Drug Testing Analytical laboratory drug testing services performed on canine samples, serving veterinary clinics, breeders, and animal sports organizations.
• Human Drug Testing Analytical laboratory drug testing services performed on human samples, serving employers, sports organizations, and clinical/medical referrers.

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Broad incumbents

• Healius Limited: Major Australian pathology operator (Laverty, Dorevitch, QML); competes for clinical and toxicology work and represents the kind of scaled incumbent RASL must compete against.
• Quest Diagnostics: Large US-based reference laboratory offering employer drug testing, forensic toxicology, and clinical diagnostics; representative of the global commercial lab model RASL operates in, although geographically distant.
• IDEXX Laboratories: Global leader in veterinary diagnostics with reference-lab and in-clinic testing; addresses the canine (and to a lesser extent equine) diagnostic markets where RASL also competes.
• SGS Australia: Global testing, inspection and certification company with Australian life-sciences and forensic testing operations; adjacent competitor that could expand into drug-testing segments.
• Sonic Healthcare: Global diagnostics powerhouse with major Australian pathology operations; competes for human drug-testing work and provides reference laboratory services that could subsume RASL's niche offering.
• Australian Clinical Labs (ACL): One of Australia's largest pathology networks offering clinical diagnostics including some drug/toxicology screening; overlaps with RASL on the human-sample side but at vastly greater scale and geographic reach.
• Eurofins Scientific: Global testing-services group operating in pharma, food, environment, and clinical markets including drug testing; could enter or expand in Australia and compete on price and scale.

Direct peers

• Racing Analytical Services Ltd: Australia's primary equine drug-testing laboratory servicing Racing Victoria and other jurisdictions; the closest direct functional peer to RASL's equine testing line.

Emerging players

• Greencross Pet Wellbeing / Antech Diagnostics (Mars Petcare): Major veterinary diagnostic platforms in the Australian and global canine market; could vertically integrate canine drug-screening services that today may flow to RASL.

Regional players

• VDPAM Racing Chemistry Laboratory (Iowa State) / ChemCentre WA: Government and university-affiliated racing drug-testing labs (e.g., ChemCentre in Western Australia) that compete for state racing-integrity testing mandates on a regional basis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/racing-analytical-services

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RASL